Abstract
In this work we isolated a novel crotamine like protein from the Crotalus durissus cascavella venom by combination of molecular exclusion and analytical reverse phase HPLC. Its primary structure was:YKRCHKKGGHCFPKEKICLPPSSDLGKMDCRWKRK-CCKKGS GK. This protein showed a molecular mass of 4892.89 Da that was determined by Matrix Assisted Laser Desorption Ionization Time-of-flight (MALDI-TOF) mass spectrometry. The approximately pI value of this protein was determined in 9.9 by two-dimensional electrophoresis. This crotamine-like protein isolated here and that named as Cro 2 produced skeletal muscle spasm and spastic paralysis in mice similarly to other crotamines like proteins. Cro 2 did not modify the insulin secretion at low glucose concentration (2.8 and 5.6 mM), but at high glucose concentration (16.7 mM) we observed an insulin secretion increasing of 2.7–3.0-fold than to control. The Na+ channel antagonist tetrodoxin (6 mM) decreased glucose and Cro 2-induced insulin secretion. These results suggested that Na+ channel are involved in the insulin secretion. In this article, we also purified some peptide fragment from the treatment of reduced and carboxymethylated Cro 2 (RC-Cro 2) with cyanogen bromide and protease V8 from Staphylococcus aureus. The isolated pancreatic β-cells were then treated with peptides only at high glucose concentration (16.7 mM), in this condition only two peptides induced insulin secretion. The amino acid sequence homology analysis of the whole crotamine as well as the biologically-active peptide allowed determining the consensus region of the biologically-active crotamine responsible for insulin secretion was KGGHCFPKE and DCRWKWKCCKKGSG.
Similar content being viewed by others
References
N. L. Anderson N. G. Anderson (1991) Electrophoresis 12 883–906
F. M. Ashcroft (1988) Rev. Neurosci. 11 97–118 Occurrence Handle10.1146/annurev.ne.11.030188.000525
B. Baker P. Utaisincharoen A. T. Tu (1992) Arch. Biochem. Biophys. 298 325–331 Occurrence Handle10.1016/0003-9861(92)90418-V
A. L. Bieber R. H. McParland R. R. Becker (1987) Toxicon 25: 677–680 Occurrence Handle10.1016/0041-0101(87)90115-2
A. L. Bieber D. Nedelkov (1997) J. Toxicol. Toxin Rev. 16 33–52
D. L. Cameron A. T. Tu (1978) Biochem. Biophys. Acta 532 147–154
N. J. Caron Y. Torrente G. Camirand M. Bujold P. Chapdelaine K. Leriche et al. (2001) Mol. Ther. 3 310–318 Occurrence Handle10.1006/mthe.2001.0279
S. Cestele W. A. Catterall (2000) Biochimie 82 883–892 Occurrence Handle10.1016/S0300-9084(00)01174-3
C. M. Dawson P. Lebrun A. Herchuelz W. J. Malaisse A. A. Gonçalves I. Atwater (1986) Horm. Metab. Res. 18 221–224
D. Derossi G. Chassaing A. Prochiantz (1998) Trends Cell Biol. 8 84–87 Occurrence Handle10.1016/S0962-8924(97)01214-2
D. Derossi A. H. Joliot G. Chassaing A. Prochiantz (1994) J. Biol. Chem. 269 10444–10450
M. Dilber A. Phelan A. Aints A. Mohamed G. Elliott C. Edvard Smith et al. (1999) Gene Ther. 6 12–21 Occurrence Handle10.1038/sj.gt.3300838
J. L. Dimarcq P. Bulet C. Hetru J. Hoffmann (1998) Biopolymers 47 465–477 Occurrence Handle10.1002/(SICI)1097-0282(1998)47:6<465::AID-BIP5>3.0.CO;2-#
P. Donatsch D. Lower B. P. Richardson P. Taylor (1977) J. Physiol. 267 357–376
M. C. Dos Santos L. C. Ferreira W. D. Da Silva M. F. Furtado (1993) Toxicon 31 1459–1469 Occurrence Handle10.1016/0041-0101(93)90211-Z
G. Elliott P. O9Hare (1997) Cell 88 223–233 Occurrence Handle10.1016/S0092-8674(00)81843-7
S. Fawell J. Seery Y. Daikh C. Moore L. L. Chen B. Pepinsky et al. (1994) Proc. Natl. Acad. Sci. USA 91 664–668
K. G. Ford D. Darling B. Souberbielle F. Farzaneh (2000) Mech. Ageing Dev. 121 113–121 Occurrence Handle10.1016/S0047-6374(00)00202-5
J. W. Fox M. Elzinga A. T. Tu (1979) Biochemistry 18 678–684
A. Frankel C. Pabo (1988) Cell 55 1189–1193 Occurrence Handle10.1016/0092-8674(88)90263-2
S. Futaki T. Suzuki W. Ohashi T. Yagami S. Tanaka K. Ueda et al. (2001) J. Biol. Chem. 276 5836–5840 Occurrence Handle10.1074/jbc.M007540200
M. Green P. M. Loewenstein (1988) Cell 55 1179–1188 Occurrence Handle10.1016/0092-8674(88)90262-0
J. Hawiger (1999) Curr. Opin. Chem. Biol. 3 89–94 Occurrence Handle10.1016/S1367-5931(99)80016-7
J. C. Hequin (1987) Horm. Res. 27 168–178
M. Hiriat D. R. Matteson (1988) J. Gen. Physiol. 91 617–639 Occurrence Handle10.1085/jgp.91.5.617
C. J. Laure (1975) Hoppe Seylers Z. Physiol. Chem. 356 213–215
N. Maeda N. Tamiya T. R. Pattabhiraman F. E. Russel (1978) Toxicon 16 431–441 Occurrence Handle10.1016/0041-0101(78)90140-X
S. Marangoni M. H. Toyama E. C. Arantes J. R. Giglio C. A. Da Silva E. M. Carneiro et al. (1995) Biochim. Biophys. Acta 1243 309–314
S. Misler D. W. Barnett K. D. Gillis D. M. Pressel (1992) Diabetes 41 1221–1228
M. C. Morris L. Chaloin F. Heitz G. Divita (2000) Curr. Opin. Biotechnol. 11 461–466 Occurrence Handle10.1016/S0958-1669(00)00128-2
G. Nicastro L. Franzoni C. de Chiara A. C. Mancin J. R. Giglio A. Spisni (2003) Eur. J. Biochem. 270 1969–1979 Occurrence Handle10.1046/j.1432-1033.2003.03563.x
G. Rádis-Baptista N. Oguiura M. A. F. Hayashi M. E. Camargo K. F. Grego E. B. Oliveira et al. (1999) Toxicon 37 973–984 Occurrence Handle10.1016/S0041-0101(98)00226-8
Y. Samejima Y. Aoki D. Mebs (1991) Toxicon 29 461–468 Occurrence Handle10.1016/0041-0101(91)90020-R
S. R. Schwarze A. Ho A. Vocero-Akbani S. F. Dowdy (1999) Science 285 1569–1572 Occurrence Handle10.1126/science.285.5433.1569 Occurrence Handle1:CAS:528:DyaK1MXlslOru78%3D Occurrence Handle10477521
S. R. Schwarze K. A. Hruska S. F. Dowdy (2000) Trends Cell Biol. 10 290–296 Occurrence Handle10.1016/S0962-8924(00)01771-2
J. Sehlin I. B. Taljedal (1974) J. Physiol. 242 505–515
L. A. Smith J. J. Schmidt (1990) Toxicon 28 575–585 Occurrence Handle10.1016/0041-0101(90)90302-N
A. M. Soares J. R. Giglio (2003) Toxicon 42 855–868 Occurrence Handle10.1016/j.toxicon.2003.11.004
A. M. Soares W. P. Sestito S. Marcussi R. G. Stabeli S. H. Andriao-Escarso O. A. Cunha et al. (2004) Int. J. Biochem. Cell Biol. 36 258–270 Occurrence Handle10.1016/S1357-2725(03)00237-1
M. H. Toyama E. M. Carneiro S. Marangoni R. L. Barbosa G. Corso A. C. Boschero (2000) Biochim. Biophys. Acta 1474 56–60
M. H. Toyama A. M. Soares S. H. Andrião-Escarso J. C. Novello B. Oliveira J. R. Giglio et al. (2001a) Protein and Peptide Letters 8 179–786
M. H. Toyama E. M. Carneiro S. Marangoni M. E. C. Amaral L. A. Velloso A. C. Boschero (2001b) J. Protein Chem. 20 585–591 Occurrence Handle10.1023/A:1013377331569
M. H. Toyama S. Marangoni J. C. Novello G. B. Leite Prado-Franceshi M. A. Cruz-Höfling et al. (2003) Toxicon 41 493–500 Occurrence Handle10.1016/S0041-0101(02)00390-2
E. Vivés P. Brodin B. Lebleu (1997) J.Biol. Chem. 272 16010–16017 Occurrence Handle10.1074/jbc.272.25.16010
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Toyama, D.O., Boschero, A.C., Martins, M.A. et al. Structure–Function Relationship of New Crotamine Isoform from the Crotalus durissus cascavella. Protein J 24, 9–19 (2005). https://doi.org/10.1007/s10930-004-0601-1
Received:
Issue Date:
DOI: https://doi.org/10.1007/s10930-004-0601-1